Research Article
Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea
Table 1
Patient demographics and clinical characteristics of the study eyes.
| | Characteristics | 186 eyes () |
| | Age (range) | 57.8 ± 11.5 (25–85) | | Male : female (% male) | 88 : 98 (47.3%) | | Type of DM | | | Type 1 DM | 14 (7.5%) | | Type 2 DM | 172 (92.5%) | | Mean duration of DM (years) | 13.2 ± 8.9 | | HbA1c (%) | 7.1 ± 2.4 | | Grade of DR | | | NPDR (%) | 103 (55.4%) | | PDR (%) | 83 (44.6%) | | Mean duration of DME (months) | 17.3 ± 22.8 | | Type of DME | | | Focal DME (%) | 27 (14.5%) | | Diffuse DME (%) | 159 (85.5%) | | History of vitrectomy (% yes) | 31 (16.7%) | | History of cataract extraction (% yes) | 74 (39.8%) | | Mean LogMAR BCVA | 0.60 ± 0.36 | | Mean IOP (mmHg) | 15.6 ± 3.4 | | Mean CRT (m) | 491.6 ± 164.6 | | Presence of SRF (%) | 56 (30.1%) | | Previous treatment for DME | | | Treatment of naïve patients | 31 (16.7%) | | Macular laser treatment | 29 (15.6%) | | Anti-VEGF | 152 (81.7%) | | Intravitreal steroid | 42 (22.6%) |
|
|
DM, diabetes mellitus; HbA1c, glycated hemoglobin; DR, diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; DME, diabetic macular edema; LogMAR, logarithm of the minimum angle of resolution; BCVA, best-corrected visual acuity; IOP, intraocular pressure; CRT, central retinal thickness; SRF, subretinal fluid; VEGF, vascular endothelial growth factor.
|
